Latest Health News
WHO Executive Board Reviews Progress on Immunization Agenda 2030
WHO Member States emphasized integrating immunization into primary health care amid declining funding, prioritizing surveillance, outbreak response, and combating vaccine hesitancy. They called for sharper focus on IA2030 priorities and replenishment of the Contingency Fund for Emergencies.
Discussions also stressed sustaining End TB and Polio Eradication Strategies with extended timelines.
IRBM Announces Breakthrough Zika Virus Protease Inhibitor
IRBM discovered a novel allosteric inhibitor targeting Zika virus NS2B-NS3 protease, showing efficacy in preclinical models and potential against other flaviviruses like dengue. The molecule suppresses viral replication with a favorable safety profile, addressing the lack of approved antivirals or vaccines.
Funded by Region of Lazio, it advances treatments for neglected diseases.
WHO Urges Action as Half of Cataract Blindness Patients Lack Surgery Access
A Lancet study reveals nearly half of people worldwide with cataract-related blindness need surgery, with Africa facing the largest gap and women disproportionately affected. WHO calls for accelerating access to this affordable intervention to prevent avoidable blindness.
Governments must address gender and geographic inequities.
Ropeginterferon Alfa-2b Outperforms Standard Therapy for High-Risk Blood Cancer
A global trial shows ropeginterferon alfa-2b superior to anagrelide for high-risk essential thrombocythaemia patients intolerant to hydroxyurea, improving blood counts and reducing complications. The therapy controls disease more effectively and enhances patient symptoms.
FDA review for expanded approval is underway.
Griffith University Nears Chikungunya Vaccine Development
Researchers at Griffith University are developing a vaccine against chikungunya, a mosquito-borne virus posing a global health threat with severe joint pain. The breakthrough aims to prevent infections in vulnerable populations.
Further trials are anticipated to advance this critical intervention.
CryoEM Reveals Key Mechanisms in Cell Function and Actin Dynamics
Penn Medicine scientists used cryoEM to visualize actin filament elongation, showing formin and profilin roles in adding monomers, published in Nature. This fundamental insight explains cellular mechanics underlying movement and division.
Ongoing work targets shortening processes.
University of Michigan AI System Rapidly Interprets Brain MRI Scans
Researchers developed an AI that analyzes brain MRIs in seconds, identifying neurological conditions and prioritizing urgent cases accurately. This tool enhances diagnostic speed and efficiency in clinical settings.
It promises broader access to rapid neuroimaging assessment.
Neutrophils Reprogrammed by Tumors to Promote Cancer Growth
University of Geneva scientists found tumors reprogram neutrophils to fuel cancer progression instead of fighting it. This discovery reveals immune evasion mechanisms in solid tumors.
Targeting this could improve immunotherapy efficacy.
EU Set to Cut Contributions to Global Fund for AIDS, TB, and Malaria
The European Commission plans to reduce pledges to the Global Fund, reversing decades of increases amid funding pressures. This shift impacts global efforts against these infectious diseases.
Partners urge sustained commitment to prevent setbacks.
Community Health Workers Boost Vaccine Delivery in Africa Amid Aid Cuts
Gavi highlights how community health workers enhance cost-efficient vaccine access in African countries facing reduced foreign aid. This approach sustains immunization amid financing challenges.
It supports integration into routine health services.
University of Missouri Trials Nuclear Medicine Breakthrough Device
The first in-person clinical trial for a novel nuclear medicine device advances diagnostic imaging capabilities. Conducted on February 10, it tests improved precision in health assessments.
Results could transform nuclear medicine applications.